PRN/Stealth DRC An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects with Intermediate Age-Related Macular Degeneration
Research Grant
Administered By
Ophthalmology
Awarded By
PRN Pharmaceutical Research Network, LLC
Start Date
November 29, 2016
End Date
October 27, 2018
Administered By
Ophthalmology
Awarded By
PRN Pharmaceutical Research Network, LLC
Start Date
November 29, 2016
End Date
October 27, 2018